Literature DB >> 7850757

Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype.

H Hasle1, N Clausen, B Pedersen, K Bendix-Hansen.   

Abstract

Trisomy 8 is a frequently acquired cytogenetic abnormality in myeloid malignancies, but may also represent a constitutional chromosome abnormality with a wide phenotypic variation. We report a case of myelodysplastic syndrome (MDS) that developed in a child with trisomy 8 mosaicism and normal phenotype. Bone marrow (BM) cells all showed trisomy 8 with additional clonal abnormalities in most cells. Based on the present case and a review of previously published cases of myeloid malignancies in patients with trisomy 8 mosaicism, it appears likely that the malignant cells developed from the trisomic cell population, suggesting that constitutional trisomy 8 may be a predisposing condition to myeloid malignancies. Trisomy 8 in malignant cells is usually considered an acquired abnormality, but this implies a risk of ignoring a constitutional trisomy 8 mosaicism. Examination for constitutional trisomy 8, despite a normal phenotype, may therefore be warranted in hematologic malignancies with trisomy 8 of BM cells to evaluate further the possible association and to preclude erroneous use of trisomy 8 as a tumor marker.

Entities:  

Mesh:

Year:  1995        PMID: 7850757     DOI: 10.1016/0165-4608(94)00099-w

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Authors:  Koichi Moriwaki; Atsushi Manabe; Takeshi Taketani; Akira Kikuchi; Tatsutoshi Nakahata; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2014-09-27       Impact factor: 2.490

Review 2.  Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.

Authors:  Satoshi Saida
Journal:  Curr Treat Options Oncol       Date:  2017-07

Review 3.  Myelodysplastic and myeloproliferative disorders of childhood.

Authors:  Henrik Hasle
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 4.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

5.  Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.

Authors:  Noelle V Frey; Christopher E Leid; Peter C Nowell; Ewa Tomczak; Honore T Strauser; Margaret Kasner; Steven Goldstein; Alison Loren; Edward Stadtmauer; Selina Luger; Elizabeth Hexner; Joanne Hinkle; David L Porter
Journal:  Am J Hematol       Date:  2008-11       Impact factor: 10.047

6.  Myelodysplastic syndromes in children: where are we today?

Authors:  A T K Rau; A K Shreedhara; S Kumar
Journal:  Ochsner J       Date:  2012

7.  Array-CGH as an adjuvant tool in cytogenetic diagnosis of pediatric MDS and JMML.

Authors:  Amanda Gonçalves Silva; Mariana Maschietto; Daniel Onofre Vidal; Leandro Mota Peliçario; Elvira Deolinda Rodrigues Pereira Velloso; Luiz Fernando Lopes; Ana Cristina Krepischi; Carla Rosenberg
Journal:  Med Oncol       Date:  2013-10-02       Impact factor: 3.064

8.  Trisomy 8 in leukemia: A GCRI experience.

Authors:  Sonal R Bakshi; Manisha M Brahmbhatt; Pina J Trivedi; Esha N Dalal; Dharmesh M Patel; Sejal S Purani; Shilin N Shukla; Pankaj M Shah; Prabhudas S Patel
Journal:  Indian J Hum Genet       Date:  2012-01

9.  Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group.

Authors:  A Mezzelani; S Tornielli; F Minoletti; M A Pierotti; G Sozzi; S Pilotti
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

10.  Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?

Authors:  Sílvia Saumell; Francesc Solé; Leonor Arenillas; Julia Montoro; David Valcárcel; Carme Pedro; Carmen Sanzo; Elisa Luño; Teresa Giménez; Montserrat Arnan; Helena Pomares; Raquel De Paz; Beatriz Arrizabalaga; Andrés Jerez; Ana B Martínez; Judith Sánchez-Castro; Juan D Rodríguez-Gambarte; José M Raya; Eduardo Ríos; María Rodríguez-Rivera; Blanca Espinet; Lourdes Florensa
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.